205 related articles for article (PubMed ID: 10428022)
21. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
[TBL] [Abstract][Full Text] [Related]
22. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
Doxey JC; Roach AG; Smith CF
Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological identification of the major subtypes of adrenoceptors involved in the canine external carotid vasoconstrictor effects of adrenaline and noradrenaline.
Willems EW; Valdivia LF; Ramírez-San Juan E; Saxena PR; Villalón CM
Life Sci; 2001 Jun; 69(2):143-53. PubMed ID: 11441904
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of postsynaptic alpha2-adrenoceptors of the dog mesenteric and rat femoral veins.
Paiva MQ; Morato M; Moura D; Guimarães S
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):165-70. PubMed ID: 10494886
[TBL] [Abstract][Full Text] [Related]
25. Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.
McDaid J; Docherty JR
Br J Pharmacol; 2001 Jun; 133(3):429-37. PubMed ID: 11375260
[TBL] [Abstract][Full Text] [Related]
26. Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors.
Takei R; Ikegaki I; Shibata K; Tsujimoto G; Asano T
Jpn J Pharmacol; 1999 Apr; 79(4):447-54. PubMed ID: 10361884
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological identification of α1- and α2-adrenoceptor subtypes involved in the vasopressor responses induced by ergotamine in pithed rats.
Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Centurión D
Eur J Pharmacol; 2013 Sep; 715(1-3):262-9. PubMed ID: 23707349
[TBL] [Abstract][Full Text] [Related]
28. Nature of alpha 1 and postjunctional alpha 2 adrenoceptors in the pulmonary vascular bed.
Hyman AL; Lippton HL; Kadowitz PJ
Fed Proc; 1986 Aug; 45(9):2336-40. PubMed ID: 3015686
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological analysis of postjunctional alpha-adrenoceptors mediating contractions to (-)-noradrenaline in the rabbit isolated lateral saphenous vein can be explained by interacting responses to simultaneous activation of alpha 1- and alpha 2-adrenoceptors.
Daly CJ; McGrath JC; Wilson VG
Br J Pharmacol; 1988 Oct; 95(2):485-500. PubMed ID: 2906557
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
[TBL] [Abstract][Full Text] [Related]
31. Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors.
Oriowo MA; Hieble JP; Ruffolo RR
Pharmacology; 1991; 43(1):1-13. PubMed ID: 1683709
[TBL] [Abstract][Full Text] [Related]
32. Postjunctional alpha-adrenoceptors. Alpha 1 and alpha 2 subtypes in rat vasculature in vitro and in vivo.
Decker N; Ehrhardt JD; Leclerc G; Schwartz J
Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):1-6. PubMed ID: 6147758
[TBL] [Abstract][Full Text] [Related]
33. Unusual alpha-adrenoceptor subtype in canine saphenous vein: comparison to mesenteric vein.
Daniel EE; Low AM; Gaspar V; Lu-Chao H; Green J; Akrong J; Duerksen S; Soyka C; Chen CK; Boyd J; Kwan CY
Br J Pharmacol; 1996 Apr; 117(7):1535-43. PubMed ID: 8730751
[TBL] [Abstract][Full Text] [Related]
34. Characterization of alpha-adrenoceptor subtypes in smooth muscle of equine ileum.
Re G; Badino P; Odore R; Galaverna D; Girardi C
Am J Vet Res; 2001 Sep; 62(9):1370-4. PubMed ID: 11560262
[TBL] [Abstract][Full Text] [Related]
35. Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat.
Docherty JR
Eur J Pharmacol; 2012 Mar; 679(1-3):90-4. PubMed ID: 22290390
[TBL] [Abstract][Full Text] [Related]
36. Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo.
Drew GM; Whiting SB
Br J Pharmacol; 1979 Oct; 67(2):207-15. PubMed ID: 40647
[TBL] [Abstract][Full Text] [Related]
37. Possible relationship between receptor reserve and the differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by calcium channel antagonists in the pithed rat.
Ruffolo RR; Morgan EL; Messick K
J Pharmacol Exp Ther; 1984 Sep; 230(3):587-94. PubMed ID: 6088757
[TBL] [Abstract][Full Text] [Related]
38. alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator.
Orito K; Kishi M; Imaizumi T; Nakazawa T; Hashimoto A; Mori T; Kambe T
Br J Pharmacol; 2001 Oct; 134(4):763-70. PubMed ID: 11606316
[TBL] [Abstract][Full Text] [Related]
39. Fentanyl attenuates alpha1B-adrenoceptor-mediated pulmonary artery contraction.
Sohn JT; Ding X; McCune DF; Perez DM; Murray PA
Anesthesiology; 2005 Aug; 103(2):327-34. PubMed ID: 16052115
[TBL] [Abstract][Full Text] [Related]
40. Selectivity of raubasine stereoisomers for alpha 1- and alpha 2-adrenoceptors in the rat.
Roquebert J
Arch Int Pharmacodyn Ther; 1986 Aug; 282(2):252-61. PubMed ID: 3021076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
